Peer reviewed
KPV and alpha-MSH-derived tripeptides: anti-inflammatory activity in preclinical models
Preclinical studies of KPV (Lys-Pro-Val), a tripeptide derived from alpha-melanocyte-stimulating hormone (alpha-MSH), showing anti-inflammatory effects in animal models of intestinal and systemic inflammation. No human clinical trials have been published.
PubMed / NCBIPublished 2018-01-01Accessed 2026-07-03
Registry record
Source metadata
- Publisher
- PubMed / NCBI
- Source type
- Peer reviewed
- Registry ID
pubmed-kpv-anti-inflammatory
Interpretation boundary
What this record can and cannot establish
Inclusion in the registry is not endorsement. The record supports only the claims that fit its design, population, date, and scope. Company, media, and community records can document that a claim was made without proving the claim itself.